Namenda

Type: Product

Name: Namenda

First reported 1 hour ago - Updated 1 hour ago - 1 reports

FOREST LABORATORIES INC - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations

Forest Laboratories, Inc., (herein referred to as "the Company," "we" or "our") is a pharmaceutical company that develops, manufactures, and sells branded forms of ethical drug products, most of which require a physician's prescription. Our primary and ... [Published Pharmacy Choice - 1 hour ago]

Entities: Research & Development, Namenda, Viibryd, Lexapro, Daliresp

First reported 8 hours ago - Updated 8 hours ago - 1 reports

Forest Laboratories Inc

Forest Labs climbs as CEO announces retirement

NEW YORK -- Shares of Forest Laboratories Inc. rose to a year high Thursday after the drugmaker said Howard Solomon, its CEO for 36 years, will retire at the end of 2013.THE SPARK: Solomon, 85, will step down as president and CEO on Dec. 31, and will ... [Published CNBC - 8 hours ago]

Entities: Howard Solomon, Forest Laboratories Inc, David Solomon

First reported 13 hours ago - Updated 13 hours ago - 1 reports

Carl Icahn

UPDATE 1-Forest Labs' longtime CEO Solomon to step down at year-end

May 23 (Reuters) - Forest Laboratories Inc said Howard Solomon, its chief executive of more than 35 years, will retire at the end of this year, capping a tenure that saw the company morph from a small generic and vitamins maker to a $10 billion corpo ... [Published Reuters - 13 hours ago]

Entities: Howard Solomon, Carl Icahn, Forest Laboratories Inc, Chris Schott, Namenda

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Is There a Pill For That? Forest Labs’ Iffy Pipeline

Forest Labs (FRX) has launched several new products in the past two years – yet has demonstrated limited success in filling the earnings void created by the patent expiry for Lexapro, its erstwhile blockbuster antidepressant. Can a new generation of products ... [Published Yahoo! Finance - May 21 2013]

Entities: Forest Laboratories Inc, Viibryd, Howard Solomon, Antidepressant

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Cardinal Health Inc

NAMENDA (Memantine Hydrochloride) Tablet [Cardinal Health]

Updated Date: May 17, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - May 17 2013]

Entities: Memantine, Namenda, Cardinal Health Inc

First reported May 14 2013 - Updated May 15 2013 - 1 reports

Forest-Trevena Ink Deal Zacks

Forest Laboratories Inc. (FRX) recently signed a collaborative licensing option deal with Trevena, Inc. for the latter’s mid-stage candidate TRV027.TRV027 is being developed for the treatment of acute decompensated heart failure (:ADHF). Results on the ... [Published Yahoo! Finance - May 14 2013]

Entities: Forest Laboratories Inc, Trevena Inc, Teflaro, Namenda

First reported May 15 2013 - Updated May 15 2013 - 1 reports

Medicare Drug Program Fails to Monitor Prescription Safety

Medicare patients now enjoy greater access to prescription drugs under a plan adopted during the George W. Bush administration. But at the same time that federal officials expanded the availability of many types of medications, they also failed to ensure ... [Published AllGov - May 15 2013]

Entities: Medicare, Drugs, ProPublica

First reported May 12 2013 - Updated May 12 2013 - 2 reports

Medicare Drug Program Putting Seniors, People With Disabilities At Risk

by Tracy Weber, Charles Ornstein and Jennifer LaFleur ProPublica, May 11, 2013, 9:06 p.m. This story was co-published with The Washington Post. Ten years ago, a sharply divided Congress decided to pour billions of dollars into subsidizing the ... [Published The Huffington Post | Full News Feed - May 12 2013]

Entities: Medicare, Drugs, Patient

First reported May 07 2013 - Updated May 08 2013 - 1 reports

Drug fails to slow Alzheimer's in big study

Patients who received infusions with Gammagard fared no better than those given a dummy solution.Story HighlightsBaxter: Study missed primary endpointsGammagard is used to treat blood disordersNo new side effects were noted in the studyDEERFIELD, Ill. ... [Published USA Today - May 07 2013]

Entities: Alzheimer's Disease, Gammagard, Drugs

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Positive Data on Forest Combo Drug - Analyst Blog

Forest Laboratories, Inc. (FRX) and Almirall, S.A. recently announced positive top-line data on their chronic obstructive pulmonary disease (COPD) fixed dose combination candidate, aclidinium bromide (LAMA) and formoterol fumarate (LABA).Two fixed dose ... [Published Quote.com United States - May 07 2013]

Entities: Forest Laboratories Inc, Chronic Obstructive Pulmonary Disease, Formoterol, Phase III, Cubist Pharmaceuticals Inc

First reported Apr 27 2013 - Updated Apr 27 2013 - 1 reports

The impact of Medicare prescription drug coverage on the use of antidementia drugs

Cholinesterase inhibitors and memantine are prescribed to slow the progression dementia. Although the efficacy of these drugs has been demonstrated, their effectiveness, from the perspective of patients and caregivers, has been questioned.Little is known ... [Published 7thSpace - Apr 27 2013]

Entities: Medicare, Drugs, Namenda, Cognex Corporation, donepezil

First reported Apr 24 2013 - Updated Apr 24 2013 - 1 reports

When grandpa became Grambo II

Last week you were introduced to Jacqueline Marcell, an international speaker on eldercare, Alzheimer’s, and breast cancer, and author of the best-selling book “Elder Rage, or Take My Father... Please! How To Survive Caring for Aging Parents.”So far, ... [Published Tillsonburg News - Apr 24 2013]

Entities: Alzheimer's Disease, Aricept, Exelon Corporation, REMINYL, Health Care

Quotes

"We believe the news of Mr. Solomon's pending retirement as CEO and Chairman of FRX could be a catalyst for significant change in the company's strategy going forward" Abraham said in a report

Forest Labs climbs as CEO announces retirement [Published CNBC - 8 hours ago]

"While Howard Solomon has built an unquestionably successful company, we believe disclosure of succession plans will be viewed favorably by investors and expect Forest shares to react positively to the news" J P Morgan analyst Chris Schott said in a note

UPDATE 1-Forest Labs' longtime CEO Solomon to step down at year-end [Published Reuters - 13 hours ago]

"CMS's payments don't go to physicians, don't go to pharmacies. They go to plans, which is how our oversight framework has been established" Jonathan Blum, the agency's director of Medicare, said in an interview...

Medicare drug program fails to monitor prescribers, putting seniors and disabled at risk [Published Money Life - May 13 2013]

...In defending himself to the medical board, documents show, one of the doctor's arguments was that Medicare allowed him to prescribe as he chose. "Dr. Sternstein believes Medicare [Part] D allows wide latitude in off label use of medications" the board report states...

Medicare Drug Program Putting Seniors, People With Disabilities At Risk [Published The Huffington Post | Full News Feed - May 12 2013]

More Content

sort by: Date \| Relevance
FOREST LABORATORIES INC - 10-K - Management's D... [Published Pharmacy Choice - 1 hour ago]
Forest Labs climbs as CEO announces retirement [Published CNBC - 8 hours ago]
UPDATE 1-Forest Labs' longtime CEO Solomon to s... [Published Reuters - 13 hours ago]
Is There a Pill For That? Forest Labs’ Iffy Pip... [Published Yahoo! Finance - May 21 2013]
NAMENDA (Memantine Hydrochloride) Tablet [Cardi... [Published DailyMed Drug Label Updates for the last seven ... - May 17 2013]
Medicare Drug Program Fails to Monitor Prescrip... [Published AllGov - May 15 2013]
Forest-Trevena Ink Deal Zacks [Published Yahoo! Finance - May 14 2013]
Dangers found in Medicare drug benefit [Published Bend Bulletin - May 13 2013]
Medicare drug program fails to monitor prescrib... [Published Money Life - May 13 2013]
Medicare Drug Program Putting Seniors, People W... [Published The Huffington Post \| Full News Feed - May 12 2013]
Medicare Drug Program Fails to Monitor Prescrib... [Published Boise Weekly - May 12 2013]
Dangers found in lack of safety oversight for M... [Published Washington Post - May 12 2013]
Deals of the Week: With Option Deal, Forest Kee... [Published The IN VIVO Blog - May 10 2013]
Positive Data on Forest Combo Drug - Analyst Blog [Published Quote.com United States - May 07 2013]
Positive Data on Forest Combo Drug Zacks [Published Yahoo! Finance - May 07 2013]
Drug fails to slow Alzheimer's in big study [Published USA Today - May 07 2013]
The impact of Medicare prescription drug covera... [Published 7thSpace - Apr 27 2013]
Forest Laboratories Rating Reiterated by Zacks ... [Published American Banking News - Apr 24 2013]
When grandpa became Grambo II [Published Tillsonburg News - Apr 24 2013]
Forest Labs' Earnings Decline - Analyst Blog [Published Quote.com Germany - Apr 23 2013]
Thanks to Lexapro generics, Forest swings to lo... [Published FiercePharma - Apr 23 2013]
NAMENDA XR (Memantine Hydrochloride) Capsule, E... [Published DailyMed Drug Label Updates for the last seven ... - Apr 19 2013]
Forest Laboratories, Inc. : Pharmaceuticals and... [Published MarketResearch.com - Apr 19 2013]
Positive Data on Forest Candidate Zacks [Published Yahoo! Finance - Apr 18 2013]
Namenda & Aricept Command Over 49% of the Marke... [Published Pharmaceutical & Medical Packaging News - Apr 17 2013]
Drugs Fail to help in Improving Cognitive Skill... [Published TopNews United States - Apr 16 2013]
Drugs, supplements no help in stopping memory l... [Published Globe and Mail - Apr 15 2013]
On-Market Pricing Strategies [Published Pharmaceutical Executive - Apr 12 2013]
Action Alert: Stop the #RxRacket! [Published Prescription Access Litigation (PAL) Project - Apr 09 2013]
Paying for Delay – Putting Consumers in the Cro... [Published Prescription Access Litigation (PAL) Project - Apr 03 2013]

Blogs

sort by: Date \| Relevance
NAMENDA (Memantine Hydrochloride) Tablet [Cardi... [Published DailyMed Drug Label Updates for the last seven ... - May 17 2013] Updated Date: May 17, 2013 EST ...
Deals of the Week: With Option Deal, Forest Kee... [Published The IN VIVO Blog - May 10 2013] It’s an optimistic time for pharma dealmakers, with the Dow and the Nasdaq Biotechnology Index climbing, buyers sitting on big piles of cash, and the IPO window as wide-open as it’s been in years. But for smaller companies that have long lamented that ...
NAMENDA XR (Memantine Hydrochloride) Capsule, E... [Published DailyMed Drug Label Updates for the last seven ... - Apr 19 2013] Updated Date: Apr 19, 2013 EST ...
Action Alert: Stop the #RxRacket! [Published Prescription Access Litigation (PAL) Project - Apr 09 2013] TAKE ACTION FOR LOWER DRUG COSTS! HELP SPREAD THE WORD Consumer Catalyst has launched a social media campaign to raise awareness about how sketchy ‘Pay-for-Delay’ deals hurt consumer health! Join the discussion on twitter and share your story, using ...
Paying for Delay – Putting Consumers in the Cro... [Published Prescription Access Litigation (PAL) Project - Apr 03 2013] Reposted from the Community catalyst blog…. As we discussed here last week , the U.S. Supreme Court is currently deliberating over whether pharmaceutical companies can collude to reap $3.5 billion a year in excess profits from American patients. Named ...